PROTAC 9（Pfizer）

N/A

Report date: 2023/03/02 16:29:52
NME

Base Information

Drug NamePROTAC 9（Pfizer）
Drug Alias NamePROTAC 9（Pfizer）
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK degradersCereblon modulators
TargetsTyrosine-protein kinase BTKCereblon
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHui Zhi Pharmaceutical (Dalian) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A